References: Principles of NSAID use for musculoskeletal pain
Australian and New Zealand College of Anaesthetists (ANZCA), Faculty of Pain Medicine (FPM), Schug SA, Palmer GM, Scott DA, Alcock M, et al. Acute Pain Management: Scientific Evidence. 5th ed. Melbourne: Australian and New Zealand College of Anaesthetists; 2020. Accessed 29 Dec 2022. https://www.anzca.edu.au/apsme5
Bally M, Dendukuri N, Rich B, Nadeau L, Helin-Salmivaara A, Garbe E, et al. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. Bmj 2017;357:j1909. https://pubmed.ncbi.nlm.nih.gov/28487435/
Daniel S, Koren G, Lunenfeld E, Bilenko N, Ratzon R, Levy A. Fetal exposure to nonsteroidal anti-inflammatory drugs and spontaneous abortions. CMAJ 2014;186(5):E177-82. https://www.ncbi.nlm.nih.gov/pubmed/24491470
Derry S, Conaghan P, Da Silva JA, Wiffen PJ, Moore RA. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev 2016;4(4):CD007400. https://www.ncbi.nlm.nih.gov/pubmed/27103611
Derry S, Moore RA, Gaskell H, McIntyre M, Wiffen PJ. Topical NSAIDs for acute musculoskeletal pain in adults. Cochrane Database Syst Rev 2015;2015(6):CD007402. https://www.ncbi.nlm.nih.gov/pubmed/26068955
Dreischulte T, Morales DR, Bell S, Guthrie B. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury. Kidney Int 2015;88(2):396-403. https://www.ncbi.nlm.nih.gov/pubmed/25874600
Flint J, Panchal S, Hurrell A, van de Venne M, Gayed M, Schreiber K, et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice. Rheumatology (Oxford) 2016;55(9):1698-702. https://www.ncbi.nlm.nih.gov/pubmed/26750125
Gladding PA, Webster MW, Farrell HB, Zeng IS, Park R, Ruijne N. The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers. Am J Cardiol 2008;101(7):1060-3. https://pubmed.ncbi.nlm.nih.gov/18359332/
Gooch K, Culleton BF, Manns BJ, Zhang J, Alfonso H, Tonelli M, et al. NSAID use and progression of chronic kidney disease. Am J Med 2007;120(3):280 e1-7. https://www.ncbi.nlm.nih.gov/pubmed/17349452
Kang DO, An H, Park GU, Yum Y, Park EJ, Park Y, et al. Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction. J Am Coll Cardiol 2020;76(5):518-29. https://pubmed.ncbi.nlm.nih.gov/32731930/
Kidney Disease Improving Global Outcomes (KDIGO). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements 2013;3(1):622-3. https://www.kisupplements.org/issue/S2157-1716(13)X3100-4
Kuo HW, Tsai SS, Tiao MM, Liu YC, Lee IM, Yang CY. Analgesic use and the risk for progression of chronic kidney disease. Pharmacoepidemiol Drug Saf 2010;19(7):745-51. https://www.ncbi.nlm.nih.gov/pubmed/20582905
Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ 2013;346:e8525. https://www.ncbi.nlm.nih.gov/pubmed/23299844
McGettigan P, Henry D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med 2011;8(9):e1001098. https://www.ncbi.nlm.nih.gov/pubmed/21980265
Moller B, Pruijm M, Adler S, Scherer A, Villiger PM, Finckh A, et al. Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study. Ann Rheum Dis 2015;74(4):718-23. https://www.ncbi.nlm.nih.gov/pubmed/24356672
Nderitu P, Doos L, Jones PW, Davies SJ, Kadam UT. Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic review. Fam Pract 2013;30(3):247-55. https://www.ncbi.nlm.nih.gov/pubmed/23302818
Nissen SE, Yeomans ND, Solomon DH, Luscher TF, Libby P, Husni ME, et al. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. N Engl J Med 2016;375(26):2519-29. https://www.ncbi.nlm.nih.gov/pubmed/27959716
O'Neil CK, Hanlon JT, Marcum ZA. Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics. Am J Geriatr Pharmacother 2012;10(6):331-42. https://www.ncbi.nlm.nih.gov/pubmed/23036838
Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 1993;153(4):477-84. https://www.ncbi.nlm.nih.gov/pubmed/8435027
Salman S, Sherif B, Al-Zohyri A. OP0131 Effects of Some Non Steroidal Anti-Inflammatory Drugs on Ovulation in Women with Mild Musculoskeletal Pain. Annals of the Rheumatic Diseases 2015;74(Suppl 2):117.3-8. http://ard.bmj.com/content/74/Suppl_2/117.3
Scheiman JM, Fendrick AM. Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs. Arthritis Res Ther 2005;7 Suppl 4(Suppl 4):S23-9. https://www.ncbi.nlm.nih.gov/pubmed/16168078
Solomon DH, Gurwitz JH. Toxicity of nonsteroidal anti-inflammatory drugs in the elderly: is advanced age a risk factor? Am J Med 1997;102(2):208-15. https://www.ncbi.nlm.nih.gov/pubmed/9217572
Ungprasert P, Cheungpasitporn W, Crowson CS, Matteson EL. Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies. Eur J Intern Med 2015;26(4):285-91. https://www.ncbi.nlm.nih.gov/pubmed/25862494
Wei L, MacDonald TM, Jennings C, Sheng X, Flynn RW, Murphy MJ. Estimated GFR reporting is associated with decreased nonsteroidal anti-inflammatory drug prescribing and increased renal function. Kidney Int 2013;84(1):174-8. https://www.ncbi.nlm.nih.gov/pubmed/23486517
